首页> 美国卫生研究院文献>other >A novel norindeniosoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
【2h】

A novel norindeniosoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex

机译:一种新型的去甲喹啉喹啉结构揭示了拓扑异构酶I-DNA共价复合物的三元捕获的常见界面抑制剂范例。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We demonstrate that five topoisomerase I (Top 1) inhibitors (two indenoisoquinolines, two camptothecins, and one indolocarbazole) each intercalate between the base pairs flanking the cleavage site generated during the Top1 catalytic cycle and are further stabilized by a network of hydrogen bonds with Top1. The interfacial inhibition paradigm described for Top1 inhibitors can be generalized to a variety of natural products that trap macromolecular complexes as they undergo catalytic conformational changes that create hotspots for drug binding. Stabilization of such conformational states results in uncompetitive inhibition and exemplifies the relevance of screening for ligands and drugs that stabilize (“trap”) these macromolecular complexes.
机译:我们证明了五种拓扑异构酶I(Top 1)抑制剂(两种茚并异喹啉,两种喜树碱和一种吲哚并咔唑)分别插入在Top1催化循环期间产生的裂解位点两侧的碱基对之间,并通过与Top1的氢键网络进一步稳定。可以将针对Top1抑制剂描述的界面抑制范例推广到各种天然产物,这些天然产物在经历催化构象变化时会捕获大分子复合物,从而形成药物结合的热点。此类构象态的稳定导致竞争性抑制,并例证了筛选稳定(“捕获”)这些大分子复合物的配体和药物的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号